Skip to content
Monday, March 20, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value
  • UAE-based medical school MBRU earns top-level institutional accreditation
  • Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily
  • Enzo Biochem agrees to sell clinical laboratory services business to LabCorp
  • Samsung Biologics invests in capacity expansion with fifth plant
  • Gulf Medical University marks World Sleep Day with an array of activities
You are here
  • Home
  • BioNTech SE

Tag: BioNTech SE

BioNTech introduces US$43M plasmid DNA manufacturing site in Germany

3 February 20233 February 2023

GERMANY – BioNTech SE has completed the US$43 million (€40m) construction of its first proprietary plasmid DNA manufacturing facility in Marburg, Germany, to produce an important building block in mRNA-based…

Read More

BioNTech acquires UK-based AI startup InstaDeep for US$682M to boost manufacturing capabilities

12 January 202313 January 2023

GERMANY — BioNTech SE, a German-based immunotherapy company, has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds (US$682 million) to speed up its…

Read More

BioNTech signs multi-year pact with the UK for cancer immunotherapies

7 January 20239 January 2023

GERMANY – BioNTech SE has signed a collaboration agreement with the Government of the United Kingdom to benefit cancer patients by accelerating clinical trials for personalized mRNA immunotherapies. The strategic…

Read More

BioNTech to establish regional clinical trial hub in Taiwan for cancer therapies

20 December 202221 December 2022

TAIWAN — Germany’s BioNTech is planning to set up a clinical trial hub in Taiwan for mRNA-based cancer immunotherapies as part of its Asia-Pacific expansion, according to Taipei Times. The…

Read More

BioNTech signs research and manufacturing pact with Australia

14 October 202214 October 2022

AUSTRALIA – BioNTech SE, the German biotech that collaborated with Pfizer to develop a widely used COVID-19 vaccine, will establish research and manufacturing facilities in Australia based on the same…

Read More

BioNTech breaks ground on first mRNA vaccine manufacturing plant in Africa

24 June 202224 June 2022

RWANDA – The German pharmaceutical company BioNTech has broken ground for the production site of its COVID-19 vaccine in Rwanda’s capital, Kigali. According to BioNTech, the facility, dubbed the African…

Read More

African countries partner BioNTech SE to produce mRNA vaccines to combat COVID-19

21 February 202221 February 2022

GHANA – Ghana, Rwanda and Senegal have partnered with BioNTech SE, German biotechnology company, to fill, finish and package BioNTech mRNA vaccines to improve vaccine supply in Africa. BioNTech SE…

Read More

Cardinal Health to test drones for pharmaceutical deliveries

18 November 202118 November 2021

USA – Cardinal Health Inc. intends to test the use of drones to expedite the delivery of pills, inhalers, and other items to U.S. pharmacies, a move that the healthcare-supplies…

Read More

Pfizer, BioNTech contract Zipline to deliver Covid-19 shots in Ghana

15 November 202115 November 2021

GHANA – Zipline, the global leader in instant logistics, Pfizer Inc. and BioNTech SE have announced that Zipline has successfully completed the first long-range drone delivery of both authorized mRNA…

Read More

BioNTech inks mRNA vaccine production facility deal with Rwanda, Senegal

27 October 202127 October 2021

SENEGAL – BioNTech has signed an agreement with the Rwandan government and Institut Pasteur de Dakar in Senegal on the construction of the first mRNA vaccine manufacturing facility in Africa…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

LATEST TWEETS

HealthCare Middle East & Africa Follow

No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa, Middle East & the World

HealthCareAfro
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Gulf Pharmaceutical Industries @JulpharUAE has appointed Mr. Basel Ziyadeh as the new Chief Executive Officer of its manufacturing business

https://t.co/8AFhARFMmO

#appointments #healthcare #leadership #middleeast #UAE #pharmaceuticals #pharma #manufacturing #Sustainability

Reply on Twitter 1626130056736276482 Retweet on Twitter 1626130056736276482 Like on Twitter 1626130056736276482 1 Twitter 1626130056736276482
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Santechture has secured an undisclosed amount of funding from Gulf Capital (GC) and @ShorooqPartners to further develop its platform, expand its services, and grow its team

https://t.co/pffgXv4Dii

#Funding #Health #technologies #UAE #SaudiArabia #MiddleEast #DiGiTALhealth

Reply on Twitter 1626127995068104707 Retweet on Twitter 1626127995068104707 1 Like on Twitter 1626127995068104707 1 Twitter 1626127995068104707
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Moroccan drug maker Laprophan has entered into an exclusive cooperation agreement with @SinopharmIntl for the production of medicines

https://t.co/XqJU3BADf3

#healthcare #manufacturing #pharmaceuticals #medicines #Africa #partnerships #Health #Morocco #China #PublicHealth

Reply on Twitter 1626125115074449408 Retweet on Twitter 1626125115074449408 Like on Twitter 1626125115074449408 Twitter 1626125115074449408
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Discovery Health launches new affordable private healthcare in partnership with Clicks and Auto & General

https://t.co/J1fPrRSf2X

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory

Reply on Twitter 1626103265409781761 Retweet on Twitter 1626103265409781761 Like on Twitter 1626103265409781761 3 Twitter 1626103265409781761
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

President William Ruto officially commissions the @AarHospital

https://t.co/Z7bGiyAUHe

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #health #medical #hospital

Reply on Twitter 1626102988266962945 Retweet on Twitter 1626102988266962945 2 Like on Twitter 1626102988266962945 2 Twitter 1626102988266962945
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.